COVID-19 : convalescent plasma as a potential therapy

To the Editor: SARS-CoV-2, the cause of COVID-19, has posed a significant threat to global health. No specific treatment or effective prophylaxis has been established, and care of severely ill patients is largely supportive, with poor outcomes in those requiring ICU admission. Experimental therapies...

Full description

Saved in:
Bibliographic Details
Published in:South African medical journal 2020-07, Vol.110 (7), p.562-563
Main Authors: Vermeulen, Marion, Wasserman, Sean, Peter, Jonny, Van den Berg, Karin, Glatt, Tanya Nadia, Louw, Vernon J., Barrett, Claire L., Brittain, David
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To the Editor: SARS-CoV-2, the cause of COVID-19, has posed a significant threat to global health. No specific treatment or effective prophylaxis has been established, and care of severely ill patients is largely supportive, with poor outcomes in those requiring ICU admission. Experimental therapies include antiviral agents such as remdesivir, lopinavir/ritonavir and favipiravir, hydroxychloroquine/chloroquine, interleukin-6 inhibitors such as tocilizumab, siltuximab and sarilumab, and COVID-19 convalescent plasma (CCP).
ISSN:0256-9574
2078-5135
DOI:10.7196/SAMJ.2020.v110i7.14983